Advertisement
Loading...

Avacta Group Plc

AVCTF•PNK
Healthcare
Biotechnology
$1.02
$0.00(0.00%)
U.S. Market opens in 7h 4m

Avacta Group Plc (AVCTF) Stock Overview

Explore Avacta Group Plc’s financial performance, market position, analyst ratings, and future outlook.

Meyka AI Score

Z

Key Financials

Market Cap448.3M
P/E Ratio-8.53
EPS (TTM)$-0.12
ROE-29.83%
Fundamental Analysis

AI Price Forecasts

1 Month$0.88
3 Months$0.81
1 Year Target$0.63

AVCTF Stock Analysis & Investment Overview

Our comprehensive AI-powered analysis of Avacta Group Plc (AVCTF) provides investors with deep insights into the stock's performance, growth potential, and market positioning. With a Meyka AI Score of C+, this stock demonstrates moderate investment characteristics based on our advanced machine learning models.

The current technical analysis reveals key indicators including an RSI of 49.27, suggesting the stock is in a neutral condition. Our forecasting models predict significant price movements, with a 12-month target of $0.63.

Key financial metrics showcase the company's fundamental strength, including a P/E ratio of -8.53 and a market capitalization of 448.3M. These metrics, combined with our AI analysis, provide a comprehensive view for both institutional and retail investors.

1-Day Change
N/A
5-Day Change
-16.67%
1-Month Change
14.76%
3-Month Change
28.13%
6-Month Change
-2.38%
Year-to-Date (YTD) Change
31.76%
1-Year Change
155.55%
3-Year Change
-18.00%
5-Year Change
-70.71%
All-Time (Max) Change
-56.61%

Contact Information

https://www.avacta.com
44 1904 217 070
Thorp Arch Estate, Wetherby, NaN, LS23 7FA

Company Facts

154 Employees
IPO DateMay 22, 2020
CountryGB
Actively Trading

Frequently Asked Questions